Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV Clinical Trials in Fitzroy

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)